Taurus Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 09-12-2024
- Paid Up Capital ₹ 9.75 M
as on 09-12-2024
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.10 Cr
as on 09-12-2024
- Satisfied Charges ₹ 6.36 Cr
as on 09-12-2024
- Revenue -12.07%
(FY 2021)
- Profit -96.43%
(FY 2021)
- Ebitda 175.70%
(FY 2021)
- Net Worth 17.29%
(FY 2021)
- Total Assets 39.71%
(FY 2021)
About Taurus Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.75 M.
The company currently has active open charges totaling ₹4.10 Cr. The company has closed loans amounting to ₹6.36 Cr, as per Ministry of Corporate Affairs (MCA) records.
Harishbhai Lathiya, Mitaben Lathiya, and Vaidik Parsana serve as directors at the Company.
- CIN/LLPIN
U24100GJ2010PLC061119
- Company No.
061119
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Jun 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Taurus Life Sciences Limited offer?
Taurus Life Sciences Limited offers a wide range of products and services, including Common Disease Medicines, Allopathic Cough Syrup, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Hand Sanitizers & Personal Hygiene, Beauty Soap, Antibiotic Tablets & Capsules, Azithromycin Tablets, Antipyretic Medication, Paracetamol Tablets.
Who are the key members and board of directors at Taurus Life Sciences?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Harishbhai Lathiya | Director | 11-Oct-2021 | Current |
Mitaben Lathiya | Director | 16-Jun-2010 | Current |
Vaidik Parsana | Director | 23-Feb-2024 | Current |
Financial Performance of Taurus Life Sciences.
Taurus Life Sciences Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 12.07% decrease. The company also saw a substantial fall in profitability, with a 96.43% decrease in profit. The company's net worth Soared by an impressive increase of 17.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Taurus Life Sciences?
In 2021, Taurus Life Sciences had a promoter holding of 99.69% and a public holding of 0.31%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Ecocare Wellness LlpActive 3 years 3 months
Harishbhai Lathiya and Mitaben Lathiya are mutual person
- Taurus Parentrals Private LimitedActive 21 years 5 months
Harishbhai Lathiya and Mitaben Lathiya are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 02 Jun 2022 | ₹4.10 Cr | Open |
Others Creation Date: 09 Jul 2020 | ₹3.70 M | Satisfied |
Others Creation Date: 22 Oct 2019 | ₹2.88 Cr | Satisfied |
How Many Employees Work at Taurus Life Sciences?
Unlock and access historical data on people associated with Taurus Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Taurus Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Taurus Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.